Skip to main content
Mantapex
Which peptides will the FDA propose adding to the 503A Bulks List?
Before Oct 1, 2027Politics
Kalshi Active 7 markets·76¢ Will the U.S. Food and Drug Administration announce publication of a proposed rule that would add KPV (free base) or KPV acetate to the 503A Bulks List before Oct 1, 2027?·$0 Total Volume·-- Liquidity·-- OI
12mo·Oct 9, 2027

Track your prediction positions

Connect your Kalshi account to track your contracts, P&L, and settlements.

Wide spread
No chart data available

Markets

7
Food and Drug Administration announce publication proposed rule would add KPV (free base) KPV acetate before Oct 2027
$0 vol
76% ▲0.0%
Food and Drug Administration announce publication proposed rule would add TB-500 (free base) TB-500 acetate before Oct 2027
$0 vol
76% ▲0.0%
Food and Drug Administration announce publication proposed rule would add MOTS-c (free base) MOTS-c acetate before Oct 2027
$0 vol
76% ▲0.0%
Food and Drug Administration announce publication proposed rule would add Semax (free base) Semax acetate before Oct 2027
$0 vol
76% ▲0.0%
Food and Drug Administration announce publication proposed rule would add Epitalon (free base) Epitalon acetate before Oct 2027
$0 vol
76% ▲0.0%
Food and Drug Administration announce publication proposed rule would add KPV (free base) KPV acetate before Oct 2027
No order book data available

If the U.S. Food and Drug Administration announces publication of a proposed rule that would add BPC-157 (free base) or BPC-157 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.

Series

KXPEPTIDEAPPROVE
View Full Series

Track Your Bets on Kalshi — and Everything Else

Create a free portfolio starting with your Kalshi positions, P&L & live odds. Then add crypto wallets, exchanges, DeFi & more — all in one place.

Polymarket
Kalshi
50+ Chains
40+ Exchanges
DeFi
NFTs
16K+ Tokens
100% free· Read-only· Encrypted